February 27, 2024
Shionogi on February 26 submitted a regulatory application seeking Japanese approval for SDT-001, a video game-based therapeutic app targeting pediatric patients with ADHD. SDT-001 is the Japanese, localized version of EndeavorRx approved in the US. Shionogi had snagged the exclusive...read more